Mark Douglas Smith is Director of Teladoc Health, Inc.. Currently has a direct ownership of 8,355 shares of TDOC, which is worth approximately $76,949. The most recent transaction as insider was on Aug 15, 2024, when has been sold 4,000 shares (Common Stock) at a price of $7.08 per share, resulting in proceeds of $28,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.36K
91.85% 3M change
91.85% 12M change
Total Value Held $76,949

Mark Douglas Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
BUY
Open market or private purchase
$28,320 $7.08 p/Share
4,000 Added 32.38%
8,355 Common Stock
May 17 2022
BUY
Exercise of conversion of derivative security
-
819 Added 15.83%
4,355 Common Stock
May 14 2021
BUY
Exercise of conversion of derivative security
-
524 Added 12.91%
3,536 Common Stock

Also insider at

PHR
Phreesia, Inc. Healthcare
JAZZ
Jazz Pharmaceuticals plc Healthcare
MDS

Mark Douglas Smith

Director
Raleigh, NC

Track Institutional and Insider Activities on TDOC

Follow Teladoc Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TDOC shares.

Notify only if

Insider Trading

Get notified when an Teladoc Health, Inc. insider buys or sells TDOC shares.

Notify only if

News

Receive news related to Teladoc Health, Inc.

Track Activities on TDOC